ArticleFrontiers in genetics2023

First case report of a novel KIF13A-ALK fusion in a lung adenocarcinoma patient and response to alectinib with a 4-year follow-up.

Zheng Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.